NASDAQ: PRQRProqr Therapeutics Nv Stock Ownership - Who owns Proqr Therapeutics Nv?
Insider buying vs selling
Have Proqr Therapeutics Nv insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Bart Filius | Director | 2026-07-17 | 150,000 | $1.72 | $258.00kBuy |
| Boer Daniel Anton De | Chief Executive Officer | 2026-07-09 | 150,000 | $1.74 | $261.00kBuy |
| Boer Daniel Anton De | Chief Executive Officer | 2026-07-07 | 150,000 | $1.59 | $238.50kBuy |
| Bart Filius | Director | 2026-06-26 | 150,000 | $1.54 | $231.00kBuy |
PRQR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when PRQR insiders and whales buy or sell their stock.
PRQR Shareholders
What type of owners hold Proqr Therapeutics Nv stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Adage Capital Partners GP LLC | 5.81% | 6,253,467 | $11.13M | Institution |
| Privium Fund Management Bv | 5.08% | 5,467,149 | $9.73M | Institution |
| Aberdeen Group PLC | 3.08% | 3,316,965 | $5.90M | Institution |
| Affinity Asset Advisors LLC | 2.28% | 2,454,278 | $4.37M | Institution |
| Sio Capital Management LLC | 1.81% | 1,954,715 | $3.48M | Institution |
| Dafna Capital Management LLC | 1.46% | 1,567,561 | $2.79M | Institution |
| Kynam Capital Management LP | 1.45% | 1,566,317 | $2.79M | Institution |
| Ikarian Capital LLC | 1.39% | 1,492,229 | $2.66M | Institution |
| Morgan Stanley | 1.21% | 1,299,775 | $2.31M | Institution |
| Platinum Investment Management Ltd | 1.15% | 1,235,514 | $2.20M | Institution |
PRQR vs Biotech Stocks
Proqr Therapeutics Nv Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.